4.7 Review

The role of DKK1 in Alzheimer's disease: A potential intervention point of brain damage prevention?

Journal

PHARMACOLOGICAL RESEARCH
Volume 144, Issue -, Pages 331-335

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2019.04.033

Keywords

DKKI; Wnt signaling; Inhibitor; Alzheimer's disease; Neural regeneration

Funding

  1. National Natural Science Foundation of China [81501185]
  2. Shandong Provincial Key Research & Development Project [2017GSF218043]

Ask authors/readers for more resources

Dickkopf-1 (DKK1), a secretory glycoprotein discovered for 'inducing generation of head', is an endogenous inhibitor of the canonical Wnt/beta-catenin signaling pathway. It was found to be involved in many pathophysiological processes in vivo. Abnormal expression of Dial will alter expressions of related proteins and genes not only in canonical Wnt/beta-catenin signaling pathway but also in other signaling pathways. Previous studies of DKK1 focused on its function in tumors. In recent years, a large number of studies have shown that it plays an important role in embryonic development, neural regeneration, synaptogenesis and so on. Therefore, its role in neuropsychiatric disorders, such as neurodysplasia, cognitive impairment and emotional disorder, has attracted increasing attention. At present, the role of DKK1 in Alzheimer's disease (AD) is one of the research hot topics. This article reviewed the research progress of its role in AD in order to provide new ideas and directions for further studies on the pathogenesis and treatment of AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available